My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.

    Medina J, Fernández-Salazar LI, García-Buey L, Moreno-Otero R.

    Diabetes Care. 2004 Aug;27(8):2057-66. Review.PMID: 15277442 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

    Neuschwander-Tetri BA, Caldwell SH.

    Hepatology. 2003 May;37(5):1202-19. Review. Erratum in: Hepatology. 2003 Aug;38(2):536. PMID: 12717402 [PubMed - indexed for MEDLINE]Related articles

    3.

    Etiopathogenesis of nonalcoholic steatohepatitis.

    Chitturi S, Farrell GC.

    Semin Liver Dis. 2001;21(1):27-41. Review.PMID: 11296694 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Nonalcoholic steatohepatitis: pathogenesis and treatment]

    Park SH.

    Korean J Hepatol. 2008 Mar;14(1):12-27. Review. Korean. PMID: 18367854 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Non-alcoholic fatty liver disease--new view]

    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.

    Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Review. Polish. PMID: 18702346 [PubMed - indexed for MEDLINE]Related articles

    6.

    Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.

    Purohit V, Russo D, Coates PM.

    Alcohol. 2004 Aug;34(1):3-8.PMID: 15670659 [PubMed - indexed for MEDLINE]Related articles

    7.

    The emerging problem of nonalcoholic steatohepatitis (NASH).

    Portincasa P, Grattagliano I, Palmieri VO, Palasciano G.

    Rom J Gastroenterol. 2005 Mar;14(1):43-51. Review.PMID: 15800693 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Evolving pathophysiologic concepts in nonalcoholic steatohepatitis.

    Neuschwander-Tetri BA.

    Curr Gastroenterol Rep. 2002 Feb;4(1):31-6. Review.PMID: 11825539 [PubMed - indexed for MEDLINE]Related articles

    9.

    Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.

    Mehta K, Van Thiel DH, Shah N, Mobarhan S.

    Nutr Rev. 2002 Sep;60(9):289-93. Review.PMID: 12296456 [PubMed - indexed for MEDLINE]Related articles

    10.

    Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH).

    Yamagishi S, Nakamura K, Inoue H.

    Med Hypotheses. 2005;65(2):377-9.PMID: 15922116 [PubMed - indexed for MEDLINE]Related articles

    11.

    Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

    Farrell GC, Larter CZ.

    Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112. Review.PMID: 16447287 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pathogenesis of nonalcoholic steatohepatitis (NASH).

    Ma X, Li Z.

    Chin J Dig Dis. 2006;7(1):7-11. Review.PMID: 16412031 [PubMed - indexed for MEDLINE]Related articles

    13.

    The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

    Wanless IR, Shiota K.

    Semin Liver Dis. 2004 Feb;24(1):99-106. Review.PMID: 15085490 [PubMed - indexed for MEDLINE]Related articles

    14.

    Present and future therapeutic strategies in non-alcoholic fatty liver disease.

    Calamita G, Portincasa P.

    Expert Opin Ther Targets. 2007 Sep;11(9):1231-49. Review.PMID: 17845148 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.

    Carter-Kent C, Zein NN, Feldstein AE.

    Am J Gastroenterol. 2008 Apr;103(4):1036-42. Epub 2008 Jan 2. Review.PMID: 18177455 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.

    Chitturi S, George J.

    Curr Gastroenterol Rep. 2003 Feb;5(1):18-25. Review.PMID: 12530944 [PubMed - indexed for MEDLINE]Related articles

    17.

    Nonalcoholic steatohepatitis and the metabolic syndrome.

    Jiang J, Torok N.

    Metab Syndr Relat Disord. 2008 Spring;6(1):1-7. Review.PMID: 18370830 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment of fibrosis in nonalcoholic fatty liver disease.

    Hoteit MA, Anania FA.

    Curr Gastroenterol Rep. 2007 Mar;9(1):47-53. Review.PMID: 17335677 [PubMed - indexed for MEDLINE]Related articles

    19.

    Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.

    Anderson N, Borlak J.

    Pharmacol Rev. 2008 Sep;60(3):311-57. Review.PMID: 18922966 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Diabetes mellitus, obesity, and hepatic steatosis.

    Youssef W, McCullough AJ.

    Semin Gastrointest Dis. 2002 Jan;13(1):17-30. Review.PMID: 11944630 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity